RECRUITING

Predicton of Sepsis Recovery Performance Subtypes Pilot Study

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study addresses critically ill sepsis patients' current literature reports of ongoing post-hospital discharge weakness and hospital readmissions. This study is aimed at capture and interpretation of a complex set of tests, administered during a subject's sepsis functional recovery trajectory, particularly capturing hospital readmission's effects on survivors' physical function recovery.

Official Title

Prediction of Sepsis Recovery Physical Performance Subtypes: A Pilot Study

Quick Facts

Study Start:2023-07-11
Study Completion:2025-10-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05912413

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Sepsis requiring organ support in an ICU setting
  1. 1. inability to obtain informed consent
  2. 2. the attending physician reports that the patient's goals of care are transitioning to palliation/withdrawal of life-sustaining therapy
  3. 3. recent cancer therapy in the last 12 months
  4. 4. age \>80
  5. 5. plans to be discharged on mechanical ventilation to a Long Term Acute Care Hospital
  6. 6. planned discharge to rehabilitation facility, long-term hospital or nursing home.
  7. 7. Pregnancy

Contacts and Locations

Study Contact

peter morris, md
CONTACT
(205) 934-5555
pmorris@uabmc.edu

Principal Investigator

peter morris, md
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham (UAB) Hospital
Birmingham, Alabama, 35294
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • peter morris, md, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-11
Study Completion Date2025-10-15

Study Record Updates

Study Start Date2023-07-11
Study Completion Date2025-10-15

Terms related to this study

Additional Relevant MeSH Terms

  • Sepsis